par Vereecken, Pierre 
;Provost, Patricia;Willaert, F.;Heenen, Michel ;Bentin, Jacques
Référence Revue médicale de Bruxelles, 28, 4, page (336-344)
Publication Publié, 2007-09
;Provost, Patricia;Willaert, F.;Heenen, Michel ;Bentin, Jacques Référence Revue médicale de Bruxelles, 28, 4, page (336-344)
Publication Publié, 2007-09
Article révisé par les pairs
| Résumé : | Psoriasis is a frequent chronic disease with a typical cutaneous expression described as erythemato-squamous lesions, and sometimes, joint involvement. This disorder rarely causes death in patients, but often alters their quality of life. A better understanding of the pathophysiology of psoriasis has led to the development of new therapeutic options among which are treatments targeted on blocking T-cell activation. Thanks to these therapies we can offer the patients long lasting remission, albeit not a curative approach. The therapeutic approach towards psoriasis will be selected in a multidisciplinary spirit, and after considering the patient himself, his disease and his lifestyle. |
